Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

THE ROLE OF THE HEPATIC MICROSOMAL ETHANOL OXIDIZING SYSTEM (MEOS) FOR ETHANOL METABOLISM IN VIVO

CHARLES S. LIEBER and LEONORE M. DeCARLI
Journal of Pharmacology and Experimental Therapeutics May 1972, 181 (2) 279-287;
CHARLES S. LIEBER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LEONORE M. DeCARLI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

To assess the in vivo role of the microsomal ethanol oxidizing system (MEOS) , an improved assay procedure was developed. When corrected for losses of microsomes during the preparation, the activity of MEOS in vitro corresponded to 20 to 25% of the in vivo rate of ethanol metabolism in the rat and could account for most of the residual ethanol metabolism after inhibition of alcohol dehydrogenase by pyrazole. Under these conditions, the apparent Km of MEOS in vitro coincided with the apparent Km of the blood ethanol disappearance in vivo. Furthermore, administration of ethanol to rats for 24 days increased blood ethanol clearance, with a parallel rise in MEOS activity, whereas the activities of alcohol dehydrogenase and catalase remained unchanged or decreased. Moreover, barbiturate treatment for four to five days also increased total MEOS activity in the liver and this was accompanied by a moderate acceleration of blood ethanol clearance. The latter effect was masked however if significant amounts of barbiturates were still present in the blood when ethanol was given. In addition. administration of one dose of barbiturate slowed blood ethanol clearance and abolished its increase induced by ethanol pretreatment, suggesting that barbiturates interfere with the metabolism of ethanol. In view of the parallel increase of blood ethanol clearance in vivo and MEOS activity in vitro after ethanol or barbiturate pretreatment, it is proposed that MEOS plays a significant role in vivo, a conclusion supported by the correspondence of the kinetic data of MEOS in vitro and of blood ethanol clearance after alcohol dehydrogenase inhibition in vivo.

Footnotes

    • Received November 29, 1971.
    • Accepted February 9, 1972.
  • © 1972 by The Williams & Wilkins Co.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 181, Issue 2
1 May 1972
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
THE ROLE OF THE HEPATIC MICROSOMAL ETHANOL OXIDIZING SYSTEM (MEOS) FOR ETHANOL METABOLISM IN VIVO
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

THE ROLE OF THE HEPATIC MICROSOMAL ETHANOL OXIDIZING SYSTEM (MEOS) FOR ETHANOL METABOLISM IN VIVO

CHARLES S. LIEBER and LEONORE M. DeCARLI
Journal of Pharmacology and Experimental Therapeutics May 1, 1972, 181 (2) 279-287;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

THE ROLE OF THE HEPATIC MICROSOMAL ETHANOL OXIDIZING SYSTEM (MEOS) FOR ETHANOL METABOLISM IN VIVO

CHARLES S. LIEBER and LEONORE M. DeCARLI
Journal of Pharmacology and Experimental Therapeutics May 1, 1972, 181 (2) 279-287;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Binding, Partial Agonism, and Potentiation of α1-Adrenergic Receptor Function by Benzodiazepines: A Potential Site of Allosteric Modulation
  • Characterization and Function of the Bovine Kidney Epithelial Angiotensin Receptor Subtype 4 Using Angiotensin IV and Divalinal Angiotensin IV as Receptor Ligands
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics